Aspiriant LLC’s Analog Devices ADI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,057
Closed -$210K 318
2023
Q4
$210K Buy
+1,057
New +$189K 0.01% 295
2023
Q3
Sell
-2,140
Closed -$417K 283
2023
Q2
$417K Buy
2,140
+935
+78% +$173K 0.02% 192
2023
Q1
$238K Sell
1,205
-16
-1% -$2.87K 0.01% 246
2022
Q4
$200K Buy
+1,221
New +$191K 0.01% 268
2022
Q2
Sell
-1,346
Closed -$221K 275
2022
Q1
$221K Sell
1,346
-593
-31% -$96.1K 0.01% 258
2021
Q4
$341K Buy
1,939
+448
+30% +$79.4K 0.02% 221
2021
Q3
$250K Sell
1,491
-356
-19% -$59.7K 0.01% 208
2021
Q2
$318K Buy
1,847
+366
+25% +$58.6K 0.02% 194
2021
Q1
$230K Sell
1,481
-86
-5% -$13.2K 0.01% 194
2020
Q4
$231K Buy
+1,567
New +$208K 0.02% 191

Other funds holding ADI

Aspiriant LLC's ADI Position: Q1 2024 in Review

Aspiriant LLC sold out of Analog Devices (ADI) in Q1 2024, closing a stake of 1,057 shares — an estimated $210K sold.

Aspiriant LLC first reported a position in ADI in Q4 2020 and held it in 10 quarters. The position peaked at $417K in Q2 2023. 1,571 funds tracked by Wall St. Rank hold ADI as of Q1 2024.

  • Aspiriant LLC reported no remaining Analog Devices position as of Q1 2024 after selling out during the quarter.
  • Aspiriant LLC sold 1,057 Analog Devices shares in Q1 2024, an estimated $210K.
  • Aspiriant LLC first reported a position in Analog Devices in Q4 2020 and held it in 10 quarters.
  • Aspiriant LLC's Analog Devices position peaked at $417K in Q2 2023.
  • 1,571 funds tracked by Wall St. Rank held Analog Devices as of Q1 2024.

Based on Aspiriant LLC's 13F filing for Q1 2024, filed 15 Apr 2024.